<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="cei13284-tbl-0002" xml:lang="en" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <p>Priority list of bacterial species with anti‐microbial resistance (AMR) (WHO, February 2017) 
   <xref rid="cei13284-bib-0017" ref-type="ref">17</xref>
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1">Bacterial species</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Priority 1: Critical</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Acinetobacter baumannii</italic>, carbapenem‐resistant
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Pseudomonas aeruginosa</italic>, carbapenem‐resistant
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Enterobacteriaceae</italic>, carbapenem‐resistant, extended spectrum beta‐lactamase‐producing
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Priority 2: High</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Enterococcus faecium</italic>, vancomycin‐resistant
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Staphylococcus aureus</italic>, methicillin‐resistant, vancomycin‐intermediate and resistant
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Helicobacter pylori</italic>, clarithromycin‐resistant
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Campylobacter</italic> spp., fluoroquinolone‐resistant
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Salmonella spp.</italic>, fluoroquinolone‐resistant
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Neisseria gonorrhoeae</italic>, cephalosporin‐resistant, fluoroquinolone‐resistant
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Priority 3: Medium</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Streptococcus pneumoniae</italic>, penicillin‐non‐susceptible
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Haemophilus influenzae</italic>, ampicillin‐resistant
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Shigella</italic> spp., fluoroquinolone‐resistant
    </td>
   </tr>
  </tbody>
 </table>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
